Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 957 | 552 | 398 | 315 | 360 |
| Other Operating Activity | -1,151 | 1,232 | 464 | 3,813 | -809 |
| Operating Cash Flow | $-194 | $1,784 | $862 | $4,128 | $-449 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,548 | -703 | -1,060 | -2,577 | -1,181 |
| Other Investing Activity | -477 | 0 | 0 | -97 | 318 |
| Investing Cash Flow | $-4,024 | $-703 | $-1,060 | $-2,674 | $-863 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | -14 | -67 |
| Dividend Paid | -1,569 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 1,838 | -749 | -133 | -520 | 0 |
| Financing Cash Flow | $269 | $-749 | $-133 | $-533 | $-67 |
| Beginning Cash Position | -2,035 | -2,386 | -2,054 | -917 | 545 |
| End Cash Position | -3,881 | -2,035 | -2,386 | 65 | -917 |
| Net Cash Flow | $N/A | $N/A | $-331 | $920 | $-1,378 |
| Free Cash Flow | |||||
| Operating Cash Flow | -194 | 1,784 | 862 | 4,128 | -449 |
| Capital Expenditure | -3,616 | -703 | -1,060 | -2,772 | -1,181 |
| Free Cash Flow | -3,810 | 1,081 | -199 | 1,356 | -1,629 |